SQUAMOUS CELL CARCINOMA
Clinical trials for SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Virus-Enhanced treatment shows promise for Hard-to-Treat esophageal cancer
Disease control OngoingThis early-phase trial tests a new virus-based drug (OBP-301) combined with standard chemotherapy and radiation for people with advanced esophageal or gastroesophageal cancer who cannot have surgery. The virus is designed to infect and kill cancer cells. The main goal is to check…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: NRG Oncology • Aim: Disease control
Last updated May 01, 2026 15:28 UTC
-
New combo therapy aims to fight head and neck cancer when other treatments fail
Disease control OngoingThis study tests whether adding a drug called bavituximab to the immunotherapy pembrolizumab can help shrink tumors or slow cancer growth in people with advanced head and neck cancer that has gotten worse after standard treatments. The trial enrolled 7 adults whose cancer had pro…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated May 01, 2026 15:27 UTC
-
New shot shows promise for tough skin cancer in japanese patients
Disease control OngoingThis study tests a new drug combination (pembrolizumab plus hyaluronidase) given as a shot under the skin for Japanese patients with advanced skin cancer that has spread or cannot be removed by surgery. The goal is to see if the drug can shrink tumors and control the disease. Abo…
Matched conditions: SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Apr 29, 2026 15:15 UTC